Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
The Exchange has sought clarification from Bal Pharma Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Ob...more...
Filing of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.more...
Bal Pharma Limited has informed the Exchange that Board of Directors at its meeting held on May 27 2026 recommended Final Dividend of Rs. 1.20 per eq...more...
Bal Pharma Limited has submitted to the Exchange the financial results for the period ended March 31 2026.more...
Audited financial results of the company for the quarter and financial year ended 31.03.2026.more...
Board of Directors of the Company has met today and transacted following business \r\n1. Approved audited financial results of the Company for the qu...more...
The company reported standalone net profit of Rs 3.70 crore for the quarter ended March 31 2026 as compared to Rs 5.61 crore in the same per...more...
Bal Pharma Limited has informed the Exchange regarding Corrigendum to the notice for the board meeting issued on 18.05.2026more...
In addition to the agenda items mentioned in our board meeting notice dated 18.05.2025 the following agenda item will also be considered at ...more...
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approv...more...
Bal Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMPmore...
Intimation on resignation of Company Secretary & Compliance officer.more...
Shailesh Siroya has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Sub...more...
Structured Digital Database certificate for the quarter ended 31.03.2026.more...
As of March 2026 50.86% is owned by Promoters and 49.14% by Public. Among Promoters holding Indian Promoters holds 46.75% and Foreign Promot...more...
Bal Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Certificate under Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.03.2026.more...
Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...
Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited financial results of the Company for the quart...more...
BOARD MEETINGS Company Name : Majestic Research Date : 30-06-2026